Wellnex Life
IPO
£21m
Background
Acting as Nominated and Financial Adviser to Wellnex Life on its £21m dual listing on AIM
Strand Hanson acted as Nominated and Financial Adviser to Wellnex Life on its £21m dual listing on AIM. Wellnex Life is an Australian-incorporated company based in Melbourne and is in the business of developing, licensing, marketing, and distributing consumer healthcare and pharmaceutical products, which are available in leading retailers and wholesalers across Australia. AIM Admission forms a key part of the Company’s strategy to continue to bring to market innovative products, increase distribution with a particular focus on international markets and take further advantage of the Company’s strong supply agreements with Haleon and others.
James Harris, Head of Corporate at Strand Hanson, said:
"We are delighted to have advised Wellnex Life on its dual listing on AIM at what is a very exciting time for the company. This transaction marks the fith listing/RTO we have completed in the past six months, in what has been a very busy period for our business. This deal also adds to our growing healthcare client list, one of the sectors we are very much focused on for the future."
The Strand Hanson team was led by James Harris and Richard Johnson, with the support of Robert Collins, Abigail Wennington and Harry Marshall.